NCT06413992 2024-05-14Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial CancerCancer Institute and Hospital, Chinese Academy of Medical SciencesPhase 2 Recruiting117 enrolled
NCT05550558 2022-09-28CAN-RESPONDSun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityPhase 2 Not yet recruiting43 enrolled